Principles of appropriate antibiotic use

International Journal of Antimicrobial Agents

Volumn 26, Issue SUPPL. 3, 2005, Pages

  Niederman, Michael S ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Compliance; Resistance; Short course therapy

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; KETOLIDE; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MOXIFLOXACIN; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; SULFONAMIDE; TELITHROMYCIN;

ANTIBIOTIC RESISTANCE; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; DRUG USE; HEALTH CARE COST; HUMAN; MEDICAL PRACTICE; PATIENT COMPLIANCE; PENICILLIN RESISTANCE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; SHORT COURSE THERAPY; STREPTOCOCCUS PNEUMONIAE; VIRUS INFECTION;

EID: 33644924347     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(05)80324-3     Document Type: Article

References (19)

1. Steinman M.A., Gonzales R., and Linder J.A. Changing use of antibiotics in community-based outpatient practice, 1991-1999 Ann Intern Med 138 2003 525 533
2. McNulty C.A., Kane A., and Foy C.J. Primary care workshops can reduce and rationalize antibiotic prescribing J Antimicrob Chemother 46 2000 493 499
3. Linder J.A., and Singer D.E. Desire for antibiotics and antibiotic prescribing for adults with upper respiratory tract infections J Gen Intern Med 18 2003 795 801
4. Marrie T.J., Peeling R.W., and Fine M.J. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course Am J Med 101 1996 508 515
5. Gilbert K., Gleason P.P., and Singer D.E. Variations in antimicrobial use and cost in more than 2,000 patients with community-acquired pneumonia Am J Med 104 1998 17 27
6. British Thoracic Society Standards of Care Committee BTS Guidelines for the Management of Community Acquired Pneumonia in Adults Thorax 56 Suppl 4 2001 iv1 iv64
7. Gleason P.P., Kapoor W.N., and Stone R.A. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia JAMA 278 1997 32 39
8. Lautenbach E., Larosa L.A., and Kasbekar N. Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use Arch Intern Med 163 2003 601 605
9. Malcolm C., and Marrie T.J. Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting Arch Intern Med 163 2003 797 802
10. Ruhe J.J., and Hasbun R. Streptococcus pneumoniae bacteremia: duration of previous antibiotic use and association with penicillin resistance Clin Infect Dis 36 2003 1132 1138
11. Anderson K.B., Tan J.S., and File T.M. Jr. Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia Clin Infect Dis 37 2003 376 381
12. Davidson R., Cavalcanti R., and Brunton J.L. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia N Engl J Med 346 2002 747 750
13. Claxton A.J., Cramer J., and Pierce C. A systematic review of the associations between dose regimens and medication compliance Clin Ther 23 2001 1296 1310
14. Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections J Antimicrob Chemother 49 2002 897 903
15. File T.M. Jr. Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia Clin Infect Dis 39 Suppl 3 2004 S159 S164
16. Socan M. Treatment of atypical pneumonia with azithromycin: comparison of a 5-day and a 3-day course J Chemother 10 1998 64 68
17. O'Doherty B., and Muller O. Randomized, multicentre study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of adults with mild to moderate community-acquired pneumonia. Azithromycin Study Group Eur J Clin Microbiol Infect Dis 17 1998 828 833
18. Schonwald S., Kuzman I., and Oreskovic K. Azithromycin: single 1.5g dose in the treatment of patients with atypical pneumonia syndrome - a randomized study Infection 27 1999 198 202
19. Erratum: Lancet 2003; 361:788 Pakistan Multicentre Amoxicillin Short Course Therapy (MASCOT) pneumonia study group Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial Lancet 360 2002 835 841